Nifty

:

25144.30

Sensex

:

81592.45

-155.05 (-0.61%)
-318.56 (-0.39%)

Login

Nifty
Sensex

:
:

25144.30
81592.45

-155.05 (-0.61%)
-318.56 (-0.39%)

Viyash Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

65/99

BSE: 512529 | NSE: VIYASH

Watchlist

NSE BSE

255.32

13-Nov-2026

Open
High
Low
Previous Close

253
259
247.5
252.23

Volume
Traded Value (lacs)
52 Week High
52 Week Low

3209503
811235002.93
298
178.13

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

11,275.21
65.88
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

11,301.36
N/A
4.01

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.47
19.34
35.67

EBITDA CAGR (%)

10 Years
5 Years
3 Years

31.27
42.93
60.43

PAT CAGR (%)

10 Years
5 Years
3 Years

-
34.05
396.47

P:E (Median)

8 Years
5 Years
3 Years

58.17
67.38
122.73

P:BV (Average)

8 Years
5 Years
3 Years

5.00
5.23
6.21

EV:EBITDA (Average)

8 Years
5 Years
3 Years

44.63
59.34
46.66

Earnings Forecasts:

(Updated: 14-11-2026)

Description 2026 2027 2028 2029
Adj EPS 4.09 7.9 11.2 12.83
P/E Ratio 62.43 32.32 22.80 19.90
Revenue 3356.96 3032.45 3495.05 4052.6
EBITDA 652.53 726.25 949.9 991.7
Net Income 177.29 337.35 477.33 594.33
ROA 4.05 8.07 10.11 12.64
P/B Ratio 3.83 3.31 2.87 2.87
ROE 6.64 10.13 13.77 11
FCFF 128.94 223.7 383.2 575.4
FCFF Yield 1.11 1.93 3.31 4.97
Net Debt 220 - - -
BVPS 66.64 77.13 89.03 89.1

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 390.65 339.75 14.98% 353.69 328.18 7.77% 372.49 344.32 8.18% 341.64 338.05 1.06%
Expenses 351.11 287.70 22.04% 306.54 278.73 9.98% 309.80 283.53 9.27% 271.30 279.77 -3.03%
EBITDA 39.54 52.05 -24.03% 47.15 49.45 -4.65% 62.69 60.79 3.13% 70.34 58.28 20.69%
EBIDTM 10.12% 15.32% 13.33% 15.07% 16.83% 17.66% 20.59% 17.24%
Other Income 10.74 17.32 -37.99% 14.59 12.90 13.10% 19.75 19.51 1.23% 16.29 15.97 2.00%
Interest 2.17 4.10 -47.07% 1.44 6.02 -76.08% 2.53 5.77 -56.15% 3.56 5.91 -39.76%
Depreciation 16.20 30.90 -47.57% 32.41 30.89 4.92% 31.16 30.47 2.26% 31.20 31.81 -1.92%
PBT 31.91 32.67 -2.33% 27.89 24.19 15.30% 48.75 -30.20 - 10.61 33.64 -68.46%
Tax 8.55 9.83 -13.02% 6.97 6.89 1.16% 12.94 -10.83 - 10.69 -17.49 -
PAT 23.36 22.84 2.28% 20.92 17.30 20.92% 35.81 -19.37 - -0.08 51.13 -
PATM 5.98% 6.72% 5.91% 5.27% 9.61% -5.63% -0.02% 15.13%
EPS 0.53 0.52 1.92% 0.47 0.39 20.51% 0.81 -0.44 - 0.00 1.16 -100.00%

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 987.94 850.30 16.19% 946.36 791.64 19.54% 919.96 772.31 19.12% 858.41 774.03 10.90%
Expenses 823.00 677.07 21.55% 767.98 672.87 14.13% 735.71 659.43 11.57% 682.78 674.29 1.26%
EBITDA 164.94 173.23 -4.79% 178.38 118.77 50.19% 184.25 112.88 63.23% 175.63 99.74 76.09%
EBIDTM 16.70% 20.37% 18.85% 15.00% 20.03% 14.62% 20.46% 12.89%
Other Income 11.78 7.46 57.91% 8.31 6.84 21.49% 15.92 10.22 55.77% 13.98 6.66 109.91%
Interest 13.71 17.51 -21.70% 12.51 20.43 -38.77% 14.52 20.68 -29.79% 16.75 20.64 -18.85%
Depreciation 45.33 59.11 -23.31% 61.77 55.59 11.12% 60.41 64.73 -6.67% 58.53 58.39 0.24%
PBT 117.68 102.37 14.96% 112.41 48.34 132.54% 125.24 -36.66 - 73.07 24.48 198.49%
Tax 33.03 29.47 12.08% 33.12 11.49 188.25% 58.86 -4.48 - 24.55 -17.46 -
PAT 84.65 72.90 16.12% 79.29 36.85 115.17% 66.38 -32.18 - 48.52 41.94 15.69%
PATM 8.57% 8.57% 8.38% 4.65% 7.22% -4.17% 5.65% 5.42%
EPS 1.72 2.18 -21.10% 1.51 1.27 18.90% 1.19 -1.05 - 0.88 1.78 -50.56%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,458.47 1,382.06 1,310.34 168.52 222.69 219.63 265.46 227.33 166.26 106.01 90.72 Net Sales Growth 8.01% 5.47% 677.56% -24.33% 1.39% -17.26% 16.77% 36.73% 56.83% 16.85% Cost Of Goods Sold 667.30 623.87 590.95 107.89 135.92 108.66 108.87 113.04 94.62 79.12 72.47 Gross Profit 791.17 758.19 719.39 60.63 86.77 110.97 156.59 114.29 71.64 26.89 18.25 GP Margin 54.25% 54.86% 54.90% 35.98% 38.96% 50.53% 58.99% 50.27% 43.09% 25.37% 20.12% Total Expenditure 1,238.75 1,147.53 1,102.06 195.18 249.09 231.59 241.50 206.84 163.57 124.42 121.27 Power & Fuel Cost - 83.50 79.28 12.89 13.93 11.96 12.77 12.73 8.52 2.32 2.14 % Of Sales - 6.04% 6.05% 7.65% 6.26% 5.45% 4.81% 5.60% 5.12% 2.19% 2.36% Employee Cost - 213.75 215.85 30.05 36.66 27.38 22.42 17.10 10.71 11.85 17.90 % Of Sales - 15.47% 16.47% 17.83% 16.46% 12.47% 8.45% 7.52% 6.44% 11.18% 19.73% Manufacturing Exp. - 131.91 125.73 22.39 39.30 48.21 58.70 51.52 41.13 15.87 14.85 % Of Sales - 9.54% 9.60% 13.29% 17.65% 21.95% 22.11% 22.66% 24.74% 14.97% 16.37% General & Admin Exp. - 54.63 48.80 12.12 14.79 16.29 15.28 6.90 6.12 11.05 9.92 % Of Sales - 3.95% 3.72% 7.19% 6.64% 7.42% 5.76% 3.04% 3.68% 10.42% 10.93% Selling & Distn. Exp. - 25.77 21.67 1.55 1.85 2.16 4.02 2.11 1.04 0.83 0.47 % Of Sales - 1.86% 1.65% 0.92% 0.83% 0.98% 1.51% 0.93% 0.63% 0.78% 0.52% Miscellaneous Exp. - 14.09 19.78 8.29 6.65 16.94 19.45 3.43 1.43 3.38 0.47 % Of Sales - 1.02% 1.51% 4.92% 2.99% 7.71% 7.33% 1.51% 0.86% 3.19% 3.89% EBITDA 219.72 234.53 208.28 -26.66 -26.40 -11.96 23.96 20.49 2.69 -18.41 -30.55 EBITDA Margin 15.07% 16.97% 15.90% -15.82% -11.86% -5.45% 9.03% 9.01% 1.62% -17.37% -33.68% Other Income 61.37 66.26 72.21 45.98 28.29 38.86 31.30 16.31 13.96 24.30 19.07 Interest 9.70 16.21 25.14 4.36 2.51 1.61 2.68 5.04 3.22 0.39 0.42 Depreciation 110.97 124.15 124.72 8.94 9.12 9.59 9.13 8.95 7.22 3.67 3.25 PBT 119.16 160.43 130.63 6.01 -9.75 15.69 43.45 22.81 6.20 1.82 -15.17 Tax 39.15 40.35 -9.32 -0.86 -3.67 0.89 8.77 1.47 -1.38 2.87 0.00 Tax Rate 32.85% 34.72% -18.96% 358.33% 37.64% 5.67% 21.45% 6.44% -22.26% 434.85% 0.00% PAT 80.01 75.87 58.49 0.62 -6.08 14.80 32.11 21.34 7.59 -2.20 -15.17 PAT before Minority Interest 80.01 75.87 58.49 0.62 -6.08 14.80 32.11 21.34 7.59 -2.20 -15.17 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.49% 5.49% 4.46% 0.37% -2.73% 6.74% 12.10% 9.39% 4.57% -2.08% -16.72% PAT Growth 11.28% 29.71% 9,333.87% - - -53.91% 50.47% 181.16% - - EPS 1.81 1.72 1.32 0.01 -0.14 0.34 0.73 0.48 0.17 -0.05 -0.34

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 3,712.67 3,420.31 3,006.84 1,369.73 1,420.91 1,412.82 1,361.62 1,179.24 1,039.31 847.84 683.57 Net Sales Growth 16.45% 13.75% 119.52% -3.60% 0.57% 3.76% 15.47% 13.46% 22.58% 24.03% Cost Of Goods Sold 1,695.42 1,562.73 1,470.18 759.74 833.77 793.00 694.65 605.05 543.01 462.17 356.70 Gross Profit 2,017.25 1,857.58 1,536.66 609.98 587.14 619.82 666.96 574.19 496.30 385.67 326.87 GP Margin 54.33% 54.31% 51.11% 44.53% 41.32% 43.87% 48.98% 48.69% 47.75% 45.49% 47.82% Total Expenditure 3,009.47 2,767.78 2,622.84 1,308.32 1,408.95 1,303.43 1,151.68 1,008.92 914.37 764.87 640.62 Power & Fuel Cost - 105.89 103.57 35.46 42.45 33.86 28.75 24.73 23.06 14.66 12.77 % Of Sales - 3.10% 3.44% 2.59% 2.99% 2.40% 2.11% 2.10% 2.22% 1.73% 1.87% Employee Cost - 565.50 551.97 250.57 258.38 231.37 187.22 165.06 145.95 113.83 106.22 % Of Sales - 16.53% 18.36% 18.29% 18.18% 16.38% 13.75% 14.00% 14.04% 13.43% 15.54% Manufacturing Exp. - 212.25 202.63 73.58 86.95 93.67 96.18 83.24 77.73 59.07 57.63 % Of Sales - 6.21% 6.74% 5.37% 6.12% 6.63% 7.06% 7.06% 7.48% 6.97% 8.43% General & Admin Exp. - 168.53 151.82 78.10 75.80 66.90 58.40 56.37 58.35 57.35 48.60 % Of Sales - 4.93% 5.05% 5.70% 5.33% 4.74% 4.29% 4.78% 5.61% 6.76% 7.11% Selling & Distn. Exp. - 100.37 88.42 56.70 58.00 57.11 50.00 45.16 36.29 36.87 28.78 % Of Sales - 2.93% 2.94% 4.14% 4.08% 4.04% 3.67% 3.83% 3.49% 4.35% 4.21% Miscellaneous Exp. - 52.51 54.25 54.16 53.60 27.52 36.47 29.32 29.98 20.93 28.78 % Of Sales - 1.54% 1.80% 3.95% 3.77% 1.95% 2.68% 2.49% 2.88% 2.47% 4.38% EBITDA 703.20 652.53 384.00 61.41 11.96 109.39 209.94 170.32 124.94 82.97 42.95 EBITDA Margin 18.94% 19.08% 12.77% 4.48% 0.84% 7.74% 15.42% 14.44% 12.02% 9.79% 6.28% Other Income 49.99 43.55 35.82 10.96 6.39 10.86 10.49 10.09 8.67 16.59 11.08 Interest 57.49 69.21 86.37 48.09 35.52 15.77 24.38 35.71 32.80 33.07 28.34 Depreciation 226.04 233.64 238.71 61.54 55.69 51.54 50.60 50.62 41.92 41.34 40.07 PBT 428.40 393.23 94.74 -37.26 -72.86 52.93 145.45 94.08 58.88 25.15 -14.39 Tax 149.56 124.37 -2.59 -25.03 -15.68 8.17 32.18 12.03 2.01 13.46 -0.53 Tax Rate 34.91% 35.63% -19.65% 45.80% 11.39% 15.44% 23.55% 12.79% 3.41% 56.91% 3.68% PAT 278.84 177.28 23.22 -35.87 -121.16 40.95 95.44 69.91 48.66 0.93 -11.30 PAT before Minority Interest 232.59 224.65 15.77 -29.61 -121.98 44.76 104.45 82.05 56.88 10.19 -13.86 Minority Interest -46.25 -47.37 7.45 -6.26 0.82 -3.81 -9.01 -12.14 -8.22 -9.26 2.56 PAT Margin 7.51% 5.18% 0.77% -2.62% -8.53% 2.90% 7.01% 5.93% 4.68% 0.11% -1.65% PAT Growth 133.32% 663.48% - - - -57.09% 36.52% 43.67% 5,132.26% - EPS 6.31 4.01 0.53 -0.81 -2.74 0.93 2.16 1.58 1.10 0.02 -0.26

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 3,189.07 2,908.41 1,087.23 1,058.36 1,041.09 1,029.51 886.22 917.79 948.62 1,257.33 Share Capital 87.37 50.06 49.89 49.89 49.67 49.67 49.67 49.37 48.75 48.75 Total Reserves 2,905.27 2,685.50 960.03 952.25 944.32 972.07 822.45 849.53 882.29 1,193.03 Non-Current Liabilities 50.20 102.22 24.21 -9.43 19.26 4.80 11.50 36.20 19.01 38.28 Secured Loans 6.32 77.82 0.00 0.00 0.00 0.00 15.16 20.61 0.00 13.98 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 17.31 13.27 35.80 2.54 24.51 6.59 4.09 22.30 24.39 28.88 Current Liabilities 415.77 509.10 98.16 61.61 89.56 96.62 105.24 79.87 26.69 168.71 Trade Payables 310.55 236.87 37.14 36.71 57.56 58.75 64.34 52.60 24.56 69.96 Other Current Liabilities 69.76 168.00 13.95 4.67 5.20 2.85 9.30 6.01 1.91 35.29 Short Term Borrowings 20.85 87.68 46.45 19.10 15.50 5.22 14.39 19.27 0.00 63.22 Short Term Provisions 14.61 16.56 0.61 1.13 11.30 29.81 17.22 1.99 0.21 0.24 Total Liabilities 3,655.04 3,519.73 1,209.60 1,110.54 1,149.91 1,130.93 1,002.96 1,033.86 994.32 1,464.32 Net Block 1,162.40 1,219.57 42.52 56.72 66.90 65.78 69.41 52.42 23.68 181.67 Gross Block 1,859.86 1,810.13 87.15 110.96 113.09 102.86 99.30 73.33 37.61 230.34 Accumulated Depreciation 697.45 590.56 44.63 54.24 46.19 37.08 29.89 20.90 13.93 48.67 Non Current Assets 2,692.59 2,652.66 1,104.41 1,025.43 995.04 985.95 879.01 946.46 853.77 1,095.85 Capital Work in Progress 55.42 34.40 5.14 2.20 1.40 4.34 3.72 0.03 3.12 32.26 Non Current Investment 976.82 967.81 640.30 632.47 658.47 685.11 738.95 788.16 672.67 828.43 Long Term Loans & Adv. 496.86 430.31 415.89 333.48 267.66 230.43 66.37 84.00 138.79 26.79 Other Non Current Assets 1.09 0.57 0.56 0.56 0.60 0.29 0.55 21.84 15.51 20.52 Current Assets 962.45 839.33 96.78 75.02 154.86 144.99 123.95 87.41 140.54 361.50 Current Investments 0.05 0.07 0.11 0.05 0.14 0.07 18.75 0.10 13.98 62.28 Inventories 292.87 278.60 34.54 47.95 67.99 45.79 31.42 25.33 13.83 62.53 Sundry Debtors 554.25 444.99 44.79 13.65 52.42 61.44 40.79 42.90 78.47 113.03 Cash & Bank 35.02 26.69 0.96 0.18 12.89 0.74 3.72 1.88 3.04 3.06 Other Current Assets 80.24 22.50 2.84 1.00 21.43 36.96 29.27 17.21 31.22 120.60 Short Term Loans & Adv. 73.79 66.47 13.54 12.21 19.69 33.40 25.66 15.65 30.09 114.68 Net Current Assets 546.68 330.22 -1.38 13.42 65.31 48.37 18.71 7.54 113.85 192.79 Total Assets 3,655.04 3,491.99 1,201.19 1,100.45 1,149.90 1,130.94 1,002.96 1,033.87 994.31 1,457.35

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 2,911.06 2,431.59 656.56 698.78 692.10 727.65 687.10 706.69 647.58 976.79 Share Capital 87.37 50.06 49.89 49.89 49.67 49.67 49.67 49.37 48.75 48.75 Total Reserves 2,617.78 2,201.61 529.37 592.57 595.33 670.21 623.34 638.43 581.25 912.49 Non-Current Liabilities 484.39 439.77 172.55 175.81 209.11 153.58 216.46 214.75 227.13 246.20 Secured Loans 300.25 349.13 123.76 113.95 87.25 62.52 108.88 126.94 85.14 141.76 Unsecured Loans 1.84 3.77 18.96 36.16 35.21 31.18 41.18 20.90 18.40 23.38 Long Term Provisions 40.31 32.85 72.22 21.47 55.95 27.19 13.16 30.50 28.54 34.76 Current Liabilities 945.90 1,015.11 645.54 558.76 537.35 513.11 514.86 440.41 430.93 545.32 Trade Payables 597.27 489.33 251.22 244.34 258.05 226.91 220.38 209.35 160.49 203.04 Other Current Liabilities 187.34 286.43 118.60 109.57 78.99 100.64 104.98 87.80 106.52 141.04 Short Term Borrowings 121.52 204.17 245.87 182.09 159.54 102.91 147.12 127.36 152.41 194.70 Short Term Provisions 39.77 35.18 29.86 22.76 40.77 82.66 42.38 15.90 11.51 6.54 Total Liabilities 4,545.02 4,019.82 1,531.05 1,483.76 1,486.57 1,443.00 1,463.16 1,402.10 1,342.62 1,785.53 Net Block 2,102.95 2,103.19 591.95 605.31 564.44 535.66 576.57 498.14 475.97 684.33 Gross Block 3,521.94 3,277.04 959.12 939.83 825.09 753.25 762.46 638.06 581.74 789.60 Accumulated Depreciation 1,418.99 1,173.85 367.17 334.52 260.64 217.60 185.89 139.91 105.77 105.27 Non Current Assets 2,290.47 2,208.49 689.64 693.88 678.16 676.33 738.86 795.99 804.61 1,176.02 Capital Work in Progress 70.46 43.40 15.93 55.28 11.63 30.79 13.42 22.61 18.04 32.55 Non Current Investment 0.02 0.02 0.89 0.01 36.79 76.94 131.29 179.65 221.73 363.97 Long Term Loans & Adv. 32.15 40.62 69.47 21.74 53.97 32.15 16.74 33.09 32.42 37.51 Other Non Current Assets 84.89 21.27 11.41 11.54 11.32 0.79 0.84 62.49 56.44 57.66 Current Assets 2,254.55 1,782.79 829.49 779.79 808.41 766.68 724.30 606.12 538.01 594.41 Current Investments 0.05 0.07 2.61 0.05 1.44 5.66 40.18 0.47 17.34 64.12 Inventories 803.20 682.23 346.23 346.09 347.97 264.36 219.42 200.10 158.57 160.81 Sundry Debtors 1,045.23 806.47 335.63 340.96 329.24 346.14 318.76 278.25 258.35 254.62 Cash & Bank 269.70 157.19 69.83 41.75 59.25 56.20 75.83 72.04 42.45 47.40 Other Current Assets 136.36 31.72 10.37 7.74 70.51 94.34 70.12 55.26 61.30 67.46 Short Term Loans & Adv. 117.87 105.11 64.81 43.21 62.83 77.52 55.33 46.75 56.05 54.48 Net Current Assets 1,308.65 767.67 183.95 221.03 271.06 253.57 209.44 165.71 107.08 49.08 Total Assets 4,545.02 3,991.28 1,519.13 1,473.67 1,486.57 1,443.01 1,463.16 1,402.11 1,342.62 1,770.43

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 119.12 187.94 -26.94 37.75 9.36 2.34 30.20 73.80 -4.02 -24.04 PBT 116.22 49.17 -0.24 -9.75 15.69 43.45 22.81 6.20 409.27 -0.01 Adjustment 146.55 220.80 -18.19 -0.49 -6.38 1.12 1.74 -2.19 -392.74 20.30 Changes in Working Capital -132.35 -64.28 -10.77 48.68 1.81 -25.47 7.84 70.32 -21.10 -42.97 Cash after chg. in Working capital 130.42 205.69 -29.20 38.45 11.12 19.09 32.39 74.34 -4.57 -22.68 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.30 -17.74 2.25 -0.70 -1.75 -16.76 -2.19 -0.54 0.55 -1.36 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -106.88 -410.18 5.47 -50.70 -4.25 16.55 -17.68 -114.06 15.60 -46.84 Net Fixed Assets -70.75 -1,752.24 20.87 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 Net Investments -8.99 -327.47 -7.89 26.09 26.57 72.52 30.56 -101.61 204.06 0.16 Others -27.14 1,669.53 -7.51 -78.12 -23.53 -51.79 -18.58 20.18 -410.33 2.63 Cash from Financing Activity -7.06 195.38 22.32 0.24 7.25 -21.33 -10.71 40.34 -11.78 70.97 Net Cash Inflow / Outflow 5.18 -26.85 0.84 -12.71 12.36 -2.44 1.81 0.07 -0.19 0.09 Opening Cash & Equivalents 15.79 43.15 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10 Closing Cash & Equivalent 20.97 15.79 0.93 0.08 12.80 0.44 2.87 1.07 1.00 1.19

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 322.91 344.80 30.59 16.81 30.59 114.75 115.33 116.02 45.24 -7.19 PBT 349.02 13.18 -54.65 -137.66 52.93 145.45 94.08 58.88 445.79 -16.80 Adjustment 364.38 454.63 144.97 220.72 93.73 83.98 91.41 84.47 -313.85 123.31 Changes in Working Capital -329.16 -74.15 -45.67 -51.61 -89.30 -70.89 -58.30 -27.95 -77.87 -104.37 Cash after chg. in Working capital 384.24 393.67 44.65 31.45 57.36 158.55 127.18 115.40 54.06 2.14 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -61.33 -48.87 -14.06 -14.64 -26.77 -43.79 -11.85 0.62 -8.83 -9.33 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -84.12 -447.21 -5.92 -64.96 -95.57 9.65 -72.27 -67.69 7.17 -116.18 Net Fixed Assets -70.75 -1,752.24 20.87 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 Net Investments -8.99 -327.47 -7.89 26.09 26.57 72.52 30.56 -101.61 204.06 0.16 Others -4.38 1,632.50 -18.90 -92.38 -114.85 -58.69 -73.17 66.55 -418.76 -66.71 Cash from Financing Activity -123.33 87.03 -1.44 32.23 67.26 -138.75 -42.75 -20.08 -56.96 147.44 Net Cash Inflow / Outflow 115.46 -15.38 23.24 -15.92 2.29 -14.35 0.31 28.25 -4.55 24.07 Opening Cash & Equivalents 140.30 156.18 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03 Closing Cash & Equivalent 255.76 140.30 64.81 41.57 57.50 53.74 68.10 67.79 39.54 44.10

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 68.50 109.29 40.49 40.18 40.02 41.14 35.11 36.41 38.20 50.95 ROA 2.11% 2.47% 0.05% -0.54% 1.30% 3.01% 2.10% 0.75% 33.06% 0.00% ROE 2.65% 3.12% 0.06% -0.61% 1.47% 3.39% 2.41% 0.83% 37.41% 0.00% ROCE 4.19% 3.51% 0.37% -0.68% 1.65% 4.45% 2.96% 0.99% 36.09% 0.03% Fixed Asset Turnover 0.75 1.38 1.74 2.01 2.04 2.66 2.66 3.00 2.05 0.52 Receivable days 131.95 68.22 61.84 53.54 94.31 69.43 66.55 132.93 127.17 310.76 Inventory Days 75.46 43.61 87.31 93.97 94.25 52.44 45.13 42.89 50.71 197.54 Payable days 160.14 84.62 124.91 126.58 195.35 206.34 103.60 86.82 78.05 239.99 Cash Conversion Cycle 47.28 27.21 24.24 20.93 -6.79 -84.46 8.08 88.99 99.83 268.31 Total Debt/Equity 0.01 0.07 0.05 0.02 0.02 0.01 0.04 0.05 0.00 0.07 Interest Cover 8.17 2.96 0.95 -2.88 10.75 16.26 5.53 2.93 91.09 0.97

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 61.92 89.96 23.22 25.76 25.97 28.98 27.10 27.86 25.85 39.44 ROA 5.25% 0.57% -1.96% -8.21% 3.06% 7.19% 5.73% 4.14% 26.54% -0.95% ROE 9.06% 1.11% -4.85% -18.95% 6.56% 15.00% 12.06% 8.63% 54.15% -1.74% ROCE 13.10% 4.80% -0.60% -9.71% 7.01% 16.24% 12.59% 9.24% 41.28% 0.87% Fixed Asset Turnover 1.01 1.42 1.49 1.65 1.83 1.80 1.72 1.74 1.51 0.96 Receivable days 98.80 69.32 87.51 84.11 85.48 89.12 90.45 92.53 90.49 118.40 Inventory Days 79.26 62.42 89.54 87.10 77.50 64.84 63.56 61.85 56.34 78.37 Payable days 126.90 91.93 119.04 109.97 111.61 117.51 80.72 75.36 77.04 104.11 Cash Conversion Cycle 51.16 39.81 58.01 61.25 51.38 36.45 73.29 79.02 69.78 92.66 Total Debt/Equity 0.16 0.27 0.78 0.62 0.49 0.31 0.51 0.47 0.48 0.43 Interest Cover 6.04 1.15 -0.14 -2.88 4.36 6.60 3.63 2.80 12.19 0.41

Top Investors:

kotak contra fund

haribabu bodepudi

kalidindi srihari raju

bandhan large & mid cap fund

narasimha reddy duthala

investor education and protection fund (iepf)

Annual Reports:

News Update:

Viyash Scientific’s arm incorporates wholly owned subsidiary in Vietnam
3rd Nov 2026, 09:12 AM

The entity is proposed to commercialize its products primarily through a distributor network, while also catering directly to select strategic key accounts
Read More
Viyash Scientific - Quarterly Results
12th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback